JTM

official impact factor 3.51

Open Access Highly Access

Translational medicine: science or wishful thinking?

Martin Wehling

Journal of Translational Medicine 2008, 6:31 doi:10.1186/1479-5876-6-31

Accesses  

  • Last 30 days: 136 accesses
  • Last year: 1537 accesses
  • All time: 6391 accesses

Cited by

BioMed Central: 2 citations

Research   Open Access

Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study

Chiung-Ling Liao, Ming-Yung Lee, Yeu-Sheng Tyan, Lai-Fong Kok, Tina S Wu, Chiew-Loon Koo, Po-Hui Wang, Kuan-Chong Chao, Chih-Ping Han Journal of Translational Medicine 2009, 7:37 (28 May 2009)

Research   Open Access

Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study

Chiew-Loon Koo, Lai-Fong Kok, Ming-Yung Lee, Tina S Wu, Ya-Wen Cheng, Jeng-Dong Hsu, Alexandra Ruan, Kuan-Chong Chao, Chih-Ping Han Journal of Translational Medicine 2009, 7:25 (14 April 2009)